Guru Anand Bodhi delivers a science-backed showdown between Ozempic's GLP-1 receptor manipulation and intermittent fasting's metabolic reset. Discover which approach wins on weight loss, sustainability, and long-term health—or whether the real answer lies beyond choosing sides. For more content like this, visit QuietPlease.ai
Copyright 2025 Inception Point Ai
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.